Treatment of open angle glaucoma or ocular hypertension with preservative-free tafluprost/timolol fixed dose combination in a real-world setting: analysis by diagnostic sub-group at study entry

被引:0
|
作者
Oddone, Francesco
Saborio, Gabriela
Pavicic-Astalos, Jasna
Scorcia, Vincenzo
Moreno-Valladares, Antonio
Hollo, Gabor
机构
关键词
D O I
10.1111/j.1755-3768.2022.104
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
引用
收藏
页数:2
相关论文
共 50 条
  • [1] Treatment of open angle glaucoma or ocular hypertension with preservative-free tafluprost/timolol fixed dose combination in a real-world clinical practice setting: a cross-country subanalysis
    Oddone, Francesco
    Fassari, Claudia
    Iester, Michele
    Lopez-Lopez, Fernando
    Hollo, Gabor
    ACTA OPHTHALMOLOGICA, 2022, 100
  • [2] Treatment of Open-Angle Glaucoma and Ocular Hypertension with Preservative-Free Tafluprost/Timolol Fixed-Dose Combination Therapy: The VISIONARY Study
    Francesco Oddone
    Lucia Tanga
    Péter Kóthy
    Gábor Holló
    Advances in Therapy, 2020, 37 : 1436 - 1451
  • [3] Treatment of Open-Angle Glaucoma and Ocular Hypertension with Preservative-Free Tafluprost/Timolol Fixed-Dose Combination Therapy: The VISIONARY Study
    Oddone, Francesco
    Tanga, Lucia
    Kothy, Peter
    Hollo, Gabor
    ADVANCES IN THERAPY, 2020, 37 (04) : 1436 - 1451
  • [4] Correction to: Treatment of Open-Angle Glaucoma and Ocular Hypertension with Preservative-Free Tafluprost/Timolol Fixed-Dose Combination Therapy: The VISIONARY Study
    Francesco Oddone
    Lucia Tanga
    Péter Kóthy
    Gábor Holló
    Advances in Therapy, 2020, 37 : 3643 - 3644
  • [5] Treatment of Open-Angle Glaucoma and Ocular Hypertension with Preservative-Free Tafluprost/Timolol Fixed-Dose Combination Therapy: UK and Ireland Results from the VISIONARY Study
    Ansari, Ejaz
    Pavicic-Astalos, Jasna
    Ayan, Filis
    King, Anthony J.
    Kinsella, Matthew
    Ng, Eugene
    Nita, Anca
    ADVANCES IN THERAPY, 2021, 38 (06) : 2990 - 3002
  • [6] Treatment of Open-Angle Glaucoma and Ocular Hypertension with Preservative-Free Tafluprost/Timolol Fixed-Dose Combination Therapy: Results from the VISIONARY Study Population in Spain
    Garcia-Medina, Jose J.
    Benitez-del-Castillo, Javier
    Rodriguez-Agirretxe, Inaki
    Lopez-Lopez, Fernando
    Moreno-Valladares, Antonio
    JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS, 2022, 38 (03) : 252 - 260
  • [7] Treatment of Open-Angle Glaucoma and Ocular Hypertension with Preservative-Free Tafluprost/Timolol Fixed-Dose Combination Therapy: UK and Ireland Results from the VISIONARY Study
    Ejaz Ansari
    Jasna Pavicic-Astalos
    Filis Ayan
    Anthony J. King
    Matthew Kinsella
    Eugene Ng
    Anca Nita
    Advances in Therapy, 2021, 38 : 2990 - 3002
  • [8] Treatment of Open-Angle Glaucoma and Ocular Hypertension with the Fixed-Dose Combination of Preservative-Free Tafluprost/Timolol: Clinical Outcomes from Ophthalmology Clinics in Italy
    Oddone, Francesco
    Scorcia, Vincenzo
    Iester, Michele
    Sisto, Dario
    De Cilla, Stefano
    Bettin, Paolo
    Cagini, Carlo
    Figus, Michele
    Marchini, Giorgio
    Rossetti, Luca
    Rossi, Gemma
    Salgarello, Tommaso
    Scuderi, Gian Luca
    Staurenghi, Giovanni
    CLINICAL OPHTHALMOLOGY, 2022, 16 : 1707 - 1719
  • [9] Treatment of open-angle glaucoma and ocular hypertension with preservative-free tafluprost/timolol fixed-dose combination therapy: 6 case reports and clinical outcomes
    E. Ansari
    S. Chappiti
    J. Pavicic-Astalos
    J. C. Pinto-Bonilla
    I. Riva
    M. Sacchi
    F. Saénz-Francés
    BMC Ophthalmology, 22
  • [10] Treatment of open-angle glaucoma and ocular hypertension with preservative-free tafluprost/timolol fixed-dose combination therapy: 6 case reports and clinical outcomes
    Ansari, E.
    Chappiti, S.
    Pavicic-Astalos, J.
    Pinto-Bonilla, J. C.
    Riva, I.
    Sacchi, M.
    Saenz-Frances, F.
    BMC OPHTHALMOLOGY, 2022, 22 (01)